Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Müntefering

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neuro-Signals|November 28, 2018
Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple SclerosisPetra Hundehege, Juncal Fernandez-Orth, Pia Römer, et al.
Biological Chemistry|February 12, 2023
Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammationChristina B Schroeter, Christopher Nelke, Marcus Schewe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humansVinzenz Fleischer, Gabriel Gonzalez-Escamilla, Dumitru Ciolac, et al.
Journal of Autoimmunity|November 7, 2023
K<sub>2P</sub>2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathiesChristopher Nelke, Thomas Müntefering, Derya Cengiz, et al.
Scientific Reports|August 23, 2025
Flecainide mediated sodium channel blockade enhances blood brain barrier integrity and promotes neuroprotection in neuroinflammationMustafa Sindi, Diana Klees, Vera Dobelmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.
Journal of Neuroinflammation|November 9, 2022
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitisChristina B Schroeter, Leoni Rolfes, K S Sophie Gothan, et al.
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Journal of Neurology|March 9, 2023
Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1Chi D L Nguyen, Aura Cecilia Jimenez-Moreno, Monika Merker, et al.
Acta Neuropathologica|May 25, 2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositisCorinna Preuße, Barbara Paesler, Christopher Nelke, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neuro-Signals|November 28, 2018
Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple SclerosisPetra Hundehege, Juncal Fernandez-Orth, Pia Römer, et al.
Biological Chemistry|February 12, 2023
Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammationChristina B Schroeter, Christopher Nelke, Marcus Schewe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humansVinzenz Fleischer, Gabriel Gonzalez-Escamilla, Dumitru Ciolac, et al.
Journal of Autoimmunity|November 7, 2023
K<sub>2P</sub>2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathiesChristopher Nelke, Thomas Müntefering, Derya Cengiz, et al.
Scientific Reports|August 23, 2025
Flecainide mediated sodium channel blockade enhances blood brain barrier integrity and promotes neuroprotection in neuroinflammationMustafa Sindi, Diana Klees, Vera Dobelmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.
Journal of Neuroinflammation|November 9, 2022
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitisChristina B Schroeter, Leoni Rolfes, K S Sophie Gothan, et al.
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Journal of Neurology|March 9, 2023
Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1Chi D L Nguyen, Aura Cecilia Jimenez-Moreno, Monika Merker, et al.
Acta Neuropathologica|May 25, 2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositisCorinna Preuße, Barbara Paesler, Christopher Nelke, et al.
Pageof 3